Health Condition 1: L700- Acne vulgaris
Conditions
Interventions
Intervention1: Topical Clindamycin gel: Clindamycin 1% gel local application twice daily for 3 months
Control Intervention1: Topical Minocycline gel: Minocycline 4% gel local application once daily at
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: All patients with Mild papulopustular Acne fairly localized inflamed and non-inflamed lesions, superficial inflammatory lesions being less than 5mm in diameter according to European evidence based S3 acne guidelines
Exclusion criteria
Exclusion criteria: Patients with mild comedonal acne Patients with moderate or severe acne Patients who have been regularly using anti acne medications since the last 30 days Patients with acne conglobate, acne fulminans or drug-induced acne Patients with history of hypersensitivity to clindamycin, minocycline or ozenoxacin Patients who are unwilling or unable to comply with the study proceedings to give written, informed consent Pregnant or lactating women Patients with history of photosensitivity Hormonal or endocrine or autoimmune abnormality Topical Steroid Dependent Face
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| number of total lesion count, seperating the inflammatory and non-inflammatory lesions, evaluators global acne severity score, investigators global assessment score, patients assessment scoreTimepoint: every monthly for 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| presence of scaling, erythema, burning, itching, stingingTimepoint: every monthly for 3 months | — |
Countries
India
Contacts
Public ContactParul Bansal
Ims and Sum Hospital
Outcome results
None listed